Advanced biostimulator that promotes neocollagenesis for sustained facial volume restoration and wrinkle improvement through natural collagen production stimulation over an extended period.
ACTIVE INGREDIENTS & COMPOSITION
POLY-D,L-LACTIC ACID (PLA)
PRIMARY COMPONENT
Biodegradable spherical PLA particles that stimulate natural collagen synthesis through controlled tissue response. The spherical particle shape ensures even volume creation and prevents needle blockage during injection.
CARBOXYMETHYL CELLULOSE (CMC)
SECONDARY COMPONENT
CMC gel component provides immediate volumizing effect while serving as a carrier matrix for PLA particles, ensuring optimal distribution and biocompatibility.
TOTAL FORMULATION
200mg of combined PLA and CMC ingredients per vial in freeze-dried powder form. This biostimulator formulation is designed to restore and maintain facial volume by promoting the body's natural collagen production.
Stimulates natural collagen synthesis for sustained improvement lasting 18-24 months with progressive tissue regeneration.
02
FACIAL VOLUME RESTORATION
Restores lost facial volume and contours through dual-action mechanism: immediate CMC gel effect and long-term PLA stimulation.
03
WRINKLE IMPROVEMENT
Effectively improves both fine and deep wrinkles through enhanced skin elasticity and firmness from collagen regeneration.
04
SKIN TEXTURE ENHANCEMENT
Improves overall skin texture, elasticity, and firmness through comprehensive neocollagenesis process.
DUAL-PHASE EFFECTIVENESS
Immediate volume effect from CMC gel component lasting 3-9 months
Secondary long-term effects from collagen regeneration lasting 6-24 months
Total treatment efficacy extends up to 18-24 months
Progressive improvement through natural collagen synthesis
[BEFORE/AFTER TREATMENT RESULTS PLACEHOLDER]
STEP-BY-STEP USAGE PROTOCOL
1
PREPARATION & RECONSTITUTION
Reconstitute the freeze-dried powder with sterile distilled water. Optional: mix with 1-2 mL of 2% Lidocaine for enhanced patient comfort during treatment.
2
NEEDLE PREPARATION
Use 18G needle to withdraw the reconstituted solution, then switch to 26G needle for precise injection into the targeted treatment area.
3
INJECTION TECHNIQUE
Inject into dermal layer or subcutaneous layer depending on treatment area. The spherical PLA particles ensure smooth injection with low pressure requirements.
4
TREATMENT AREAS
Apply to entire facial area excluding glabella and eye region. Suitable for deep forehead wrinkles, nasolabial folds, temporal and cheekbone augmentation.
5
POST-TREATMENT CARE
Monitor patient response and schedule follow-up treatments as needed. Treatment cycle consists of 1-3 sessions for optimal results.
TREATMENT FREQUENCY & TIMING
Recommended treatment cycle of 1-3 treatments. Single treatment session provides immediate volume for 3-9 months, with secondary efficacy from collagen regeneration lasting 6-24 months.
APPLICATION PROTOCOLS
INJECTION LAYER SPECIFICATIONS
Target dermal layer or subcutaneous layer based on treatment objectives. Deep dermis injection for wrinkle correction, subcutaneous for volume restoration.
NEEDLE GAUGE PROTOCOL
Use 18G needle for solution withdrawal to prevent particle damage, then 26G needle for patient injection to ensure comfort and precision.
[INJECTION TECHNIQUE REFERENCE GUIDE PLACEHOLDER]
PRODUCT SPECIFICATIONS
SPECIFICATION
VALUE
DESCRIPTION
Total Volume
200mg
Per single vial
Formulation Type
Freeze-dried powder
Lyophilized spherical particles
Cross-linking
Not cross-linked
Non-cross-linked gel structure
Particle Shape
Spherical
Even volume creation
Storage Temperature
2-25°C
Room temperature storage
Shelf Life
24 months
From manufacture date
STORAGE & HANDLING CONDITIONS
Store at room temperature (2-25°C) away from direct sunlight. Keep in original packaging until use. For professional use only by certified medical professionals or dermatologists.
ROOM TEMPERATURELIGHT PROTECTIONPROFESSIONAL USE
TREATMENT DURATION & RESULTS
3-9
MONTHS
Initial volume effect duration
6-24
MONTHS
Secondary collagen effect
18-24
MONTHS
Total treatment efficacy
1-3
TREATMENTS
Recommended treatment cycle
200
MG
Active ingredient per vial
26G
NEEDLE
Recommended injection gauge
[TREATMENT TIMELINE AND RESULTS CHART PLACEHOLDER]
MANUFACTURER & QUALITY STANDARDS
MANUFACTURER INFORMATION
Manufactured by Maypharm Co., Ltd. utilizing advanced freeze-drying technology to reduce reconstitution time and ensure optimal particle integrity.
QUALITY FEATURES
Spherical PLA particles for even distribution
Low injection pressure requirements
Biodegradable materials with no residue
Freeze-drying technology for stability
Professional-grade formulation standards
SAFETY INFORMATION & PRECAUTIONS
For professional use only by certified medical professionals or dermatologists. Read complete instructions before use.
Professional administration required
Avoid glabella and eye region
Store away from direct sunlight
Use proper needle gauge specifications
Monitor patient response during treatment
Follow recommended reconstitution procedures
Maintain sterile injection techniques
Document treatment parameters
PROFESSIONAL GUIDELINES
This product is intended for use by qualified medical professionals only. Proper training in injection techniques and facial anatomy is essential for safe and effective treatment outcomes.
TECHNICAL DOCUMENTATION
FORMULATION TECHNOLOGY
MENNUS utilizes advanced freeze-drying technology combined with spherical PLA particle engineering to ensure optimal biocompatibility and treatment effectiveness.
FREEZE-DRIEDSPHERICAL PARTICLESBIOSTIMULATOR
MECHANISM OF ACTION
Dual-phase mechanism combining immediate volumizing from CMC gel with long-term collagen stimulation from PLA microspheres. The biodegradable components are naturally processed by the body, leaving enhanced tissue structure through neocollagenesis.